Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Ophthalmological Medicine
Volume 2016, Article ID 6074968, 7 pages
http://dx.doi.org/10.1155/2016/6074968
Case Report

Ophthalmic Manifestations of Hematopoietic Malignancy

1Department of Ophthalmology, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan
2Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, Japan

Received 21 January 2016; Accepted 9 May 2016

Academic Editor: Michele Iester

Copyright © 2016 Natsuyo Yoshida-Hata et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. R. Yellu, J. M. Engel, A. Ghose, and A. A. Onitilo, “Overview of recent trends in diagnosis and management of leptomeningeal multiple myeloma,” Hematological Oncology, vol. 34, no. 1, pp. 2–8, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Oechsle, V. Lange-Brock, A. Kruell, C. Bokemeyer, and M. De Wit, “Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: A Retrospective Analysis,” Journal of Cancer Research and Clinical Oncology, vol. 136, no. 11, pp. 1729–1735, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Röllig, S. Knop, and M. Bornhäuser, “Multiple myeloma,” The Lancet, vol. 385, no. 9983, pp. 2197–2208, 2015. View at Publisher · View at Google Scholar
  4. S. Fung, D. Selva, I. Leibovitch, J. Hsuan, and J. Crompton, “Ophthalmic manifestations of multiple myeloma,” Ophthalmologica, vol. 219, no. 1, pp. 43–48, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. H.-L. Ko, C.-L. Chen, and K.-H. Chi, “Frontal skull craniotomy combined with moderate-dose radiotherapy effectively ameliorate a rare case of non-secretory, multiple myeloma with orbital involvement,” World Journal of Surgical Oncology, vol. 7, article 86, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. M. Mansour and H. I. Salti, “Multiple myeloma presenting with optic nerve compression,” Eye, vol. 15, part 6, pp. 802–804, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. A. K. Nugent, Y. M. Paulus, A. Chan, J. W. Kim, E. J. Schwartz, and D. M. Moshfeghi, “Multiple myeloma recurrence with optic nerve infiltration diagnosed by vitrectomy, immunohistochemistry, and in situ hybridization,” European Journal of Ophthalmology, vol. 24, no. 3, pp. 446–448, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Özdemir, Ö. Tarkan, Ü. Tuncer, Ö. Surmelioglu, M. Dogrusoz, and M. Ergin, “A case of extramedullary plasmacytoma in the sphenoid sinus with unilateral loss of vision,” Journal of Cranio-Maxillofacial Surgery, vol. 41, no. 2, pp. 140–143, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. W. Pan, W. H. Wan Hitam, R. A. Mohd Noor, and V. M. K. Bhavaraju, “Recurrence of multiple myeloma with soft tissue plasmacytoma presenting as unilateral proptosis,” Orbit, vol. 30, no. 2, pp. 105–107, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. Riley, J. K. Russo, A. Shipp, M. Alsharif, and J. M. Jenrette, “Central nervous system myelomatosis with optic neuropathy and intramedullary spinal cord compression responding to radiation therapy,” Japanese Journal of Radiology, vol. 29, no. 7, pp. 513–516, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Shimada, M. Shibuya, R. Ohki, S. Yoneya, and Y. Nakamura, “Bilateral optic neuropathy associated with multiple myeloma,” Journal of Neuro-Ophthalmology, vol. 26, no. 2, pp. 117–120, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. S. N. Yeung, K. E. Paton, K. Dorovini-Zis, J. B. Chew, and V. A. White, “Histopathologic features of multiple myeloma involving the optic nerves,” Journal of Neuro-Ophthalmology, vol. 28, no. 1, pp. 12–16, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. S. G. U. Yilmaz, G. Ture, M. Ö. Zengin, E. Talay, and S. Men, “Optic nerve and dura mater involvement as the first sign of multiple myeloma,” European journal of ophthalmology, vol. 25, no. 1, pp. 77–79, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Khasraw and J. B. Posner, “Neurological complications of systemic cancer,” The Lancet Neurology, vol. 9, no. 12, pp. 1214–1227, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. K. Basu, S. C. Remick, M. Monga, and L. F. Gibson, “Breaking and entering into the CNS: clues from solid tumor and nonmalignant models with relevance to hematopoietic malignancies,” Clinical and Experimental Metastasis, vol. 31, no. 2, pp. 257–267, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Ravandi, J. Cortes, Z. Estrov et al., “CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia,” Leukemia Research, vol. 26, no. 7, pp. 643–649, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. J. B. Posner, Neurologic Complications of Cancer, FA Davis, Philadelphia, Pa, USA, 1995.
  18. M. Hata, K. Miyamoto, A. Oishi et al., “Measurement of retinal nerve fiber layer thickness in eyes with optic disc swelling by using scanning laser polarimetry and optical coherence tomography,” Clinical Ophthalmology, vol. 8, no. 1, pp. 105–111, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Nikaido, H. Mishima, H. Ono, K. Choshi, and H. Dohy, “Leukemic involvement of the optic nerve,” American Journal of Ophthalmology, vol. 105, no. 3, pp. 294–298, 1988. View at Publisher · View at Google Scholar · View at Scopus